Glutamic acid decarboxylase and other autoantigens in IDDM
- 31 December 1995
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 7 (6) , 825-830
- https://doi.org/10.1016/0952-7915(95)80055-7
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes.The Journal of Experimental Medicine, 1995
- Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children.Journal of Clinical Investigation, 1995
- Functional State of the β Cell Affects Expression of Both Forms of Glutamic Acid DecarboxylasePancreas, 1994
- Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetesDiabetes, 1994
- Autoantigenic Properties of Native and Denatured Glutamic Acid Decarboxylase: Evidence for a Conformational EpitopeClinical Immunology and Immunopathology, 1994
- Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic isletsDiabetes, 1993
- HLA-DQ genotypes are associated with autoimmunity to glutamic acid decarboxylase in insulin-dependent diabetes mellitus patientsHuman Immunology, 1993
- Mapping of Glutamic Acid Decarboxylase (GAD) GenesGenomics, 1993
- Regulation of glutamic acid decarboxylase diabetes autoantigen expression in highly purified isolated islets from Macaca nemestrinaEndocrinology, 1993
- Insulin autoantibodies: Their role in the pathogenesis of IDDMDiabetes/Metabolism Research and Reviews, 1987